![]() Juno Therapeutics Juno Therapeutics is a clinical-stage company, which develops immunotherapies for the treatment of cancer. | ![]() Adaptive Biotechnologies Adaptive Biotechnologies (formerly known as Adaptive TCR) is a company that develops diagnostics and therapeutic tools based on the immune response to disease. | ||
Founding Date | Founding Date 2009 | Founding Date 2013 | Founding Date 2009 |
Type | Type Subsidiary | Type Subsidiary | Type Public |
Tags | |||
Locations | Locations Santa Monica, US HQ Hoofddorp, NL London, GB El Segundo, US Emeryville, US Frederick, US Oceanside, US see more | Locations Seattle, US HQ Göttingen, DE Göttingen, DE München, DE München, DE Bothell, US Brisbane, US | Locations Seattle, US HQ New York, US South San Francisco, US |
Employees | Employees 3,9671% decrease | Employees 1091% decrease | Employees 70910% decrease |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $111.9m (FY, 2017) | Revenue (est.) $277m (FY, 2025) |
Net income | Net income N/A | Net income ($437.1m) (FY, 2017) | Net income ($59.5m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 85.3m | Total funding raised $ 310m | Total funding raised $ 525m |

Juno Therapeutics is a clinical-stage company, which develops immunotherapies for the treatment of cancer.
View company
Adaptive Biotechnologies (formerly known as Adaptive TCR) is a company that develops diagnostics and therapeutic tools based on the immune response to disease.
View company